Lincoln Pharmaceuticals Limited (LINCOLN.NS) NSE
668.15
+2.1(+0.32%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
668.15
+2.1(+0.32%)
Currency In INR
| Market Cap | 11.06B |
| Enterprise Value | 10.93B |
| P/E Ratio | 15.24 |
| PEG Ratio | -8.95 |
| Price/Sales Ratio | 2.05 |
| Price/Book Ratio | 1.87 |
| Enterprise/Revenue | 2.02 |
| Enterprise/EBITDA | 11.42 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.13 |
| Operating Margin | 0.13 |
| Return On Assets | 0.1 |
| Return On Equity | 0.13 |
| Revenue | 6.23B |
| Revenue/Share | 325.48 |
| Gross Profit | 3.32B |
| EBITDA | 1.24B |
| Net Income | 823.46M |
| Diluted EPS | 41.11 |
| Total Cash | 2.32B |
| Total Cash/Share | 115.78 |
| Total Debt | 668,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.71 |
| Book Value Per Share | 357.35 |
| 52-Week Change | 13.39 |
| 52-Week High | 733 |
| 52-Week Low | 440 |
| Moving Average 50 Days | 611.17 |
| Moving Average 200 Days | 546.8 |
| Average Volume | 121,962 |
| Shares Outstanding | 20.03M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1.8 |
| Trailing Annual Dividend Yield | 0.27 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |